Epstein-Barr Virus in Breast Cancer
Author Information
Author(s): Fina F, Romain S, Ouafik L'H, Palmari J, Ayed F Ben, Benharkat S, Bonnier P, Spyratos F, Foekens J A, Rose C, Buisson M, Gérard H, Reymond M O, Seigneurin J M, Martin P M
Primary Institution: Assistance Publique-Hôpitaux de Marseille
Hypothesis
Is there an association between Epstein-Barr virus and breast cancer across different geographical areas?
Conclusion
The study found that 31.8% of breast cancer tumors contained the Epstein-Barr virus, with higher loads in high-risk areas, but no significant differences among geographical areas.
Supporting Evidence
- 31.8% of the tumors contained the Epstein-Barr virus genome.
- Positive samples showed higher loads of the EBV genome in high-risk areas.
- EBV type 1 was the dominant strain found in the samples.
- EBV localization was restricted to some tumor epithelial cell clusters.
Takeaway
The researchers looked at breast cancer samples to see if a virus called Epstein-Barr was present, and they found it in about one-third of the samples, especially in areas where another type of cancer is more common.
Methodology
Polymerase chain reaction (PCR) was used to detect the Epstein-Barr virus in breast cancer samples from different geographical areas.
Limitations
The presence of the EBV genome was not correlated with various clinical factors such as age or tumor characteristics.
Participant Demographics
Samples were taken from breast cancer patients in high, intermediate, and low-risk geographical areas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website